Third-generation EGFR and ALK inhibitors: mechanisms of resistance and management
Alissa J. Cooper, Lecia V. Sequist, Jessica J. Lin
Topics & Concepts
OsimertinibMedicineAcquired resistanceCancer researchLung cancerAnaplastic lymphoma kinaseTyrosine kinaseDiseaseKinaseDrug resistanceCancerEpidermal growth factor receptorErlotinibOncologyBiologyInternal medicineReceptorGeneticsMalignant pleural effusionLung Cancer Treatments and MutationsCancer therapeutics and mechanismsLung Cancer Research Studies